Market Tracker

06/28 2:47pm ET
38.00
BATS BZX Real-Time Price
As of 2:46pm ET
 -2.61 / -6.43%
Today’s Change
29.51
Today|||52-Week Range
66.95
-27.37%
Year-to-Date
Is Opko Health a Buy Now That Rayaldee Is Approved?
Jun 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close40.61
Today’s open41.13
Day’s range37.99 - 41.22
Volume21,888
Average volume (3 months)592,098
Market cap$1.9B
Dividend yield--
Data as of 2:46pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-33.19%
Earnings growth (this year)-10.61%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales6,500.72
Price/Book18.83

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...+2.96+6.26%
GWPHGW Pharmaceuticals P...+5.12+5.79%
IRWDIronwood Pharmaceuti...+0.71+5.79%
GLPGGalapagos NV+2.15+4.28%
Data as of 2:46pm ET, 06/28/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)-$1.66
Annual revenue (last year)$317.0K
Annual profit (last year)-$251.4M
Net profit margin-79,308.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Leon O. Moulder
President, Chief Operating Officer &
Director
Mary Lynne Hedley
Corporate headquarters
Waltham, Massachusetts

Forecasts